Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CRAT Antikörper (N-Term)

CRAT Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN630518
  • Target Alle CRAT Antikörper anzeigen
    CRAT (Carnitine O-Acetyltransferase (CRAT))
    Bindungsspezifität
    • 5
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 23
    • 6
    • 5
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 31
    • 2
    Kaninchen
    Klonalität
    • 32
    • 1
    Polyklonal
    Konjugat
    • 20
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser CRAT Antikörper ist unkonjugiert
    Applikation
    • 22
    • 13
    • 11
    • 8
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB)
    Spezifität
    CRAT antibody was raised against the N terminal of CRAT
    Aufreinigung
    Affinity purified
    Immunogen
    CRAT antibody was raised using the N terminal of CRAT corresponding to a region with amino acids MKASSRFKAHQDALPRLPVPPLQQSLDHYLKALQPIVSEEEWAHTKQLVD
    Top Product
    Discover our top product CRAT Primärantikörper
  • Applikationshinweise
    WB: 1 µg/mL
    Optimal conditions should be determined by the investigator.
    Kommentare

    CRAT Blocking Peptide, catalog no. 33R-6123, is also available for use as a blocking control in assays to test for specificity of this CRAT antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CRAT antibody in PBS
    Konzentration
    Lot specific
    Buffer
    PBS
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Dilute only prior to immediate use.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target
    CRAT (Carnitine O-Acetyltransferase (CRAT))
    Andere Bezeichnung
    CRAT (CRAT Produkte)
    Synonyme
    CAT1 antikoerper, AW107812 antikoerper, CARAT antikoerper, CAT antikoerper, Carnitine acetylase antikoerper, CrAT antikoerper, hm:zeh0248 antikoerper, zgc:92317 antikoerper, carnitine O-acetyltransferase antikoerper, carnitine acetyltransferase antikoerper, Carnitine acetyltransferase antikoerper, Carnitine acetyltransferase, putative antikoerper, carnitine O-acetyltransferase a antikoerper, CRAT antikoerper, Crat antikoerper, CNA05200 antikoerper, CNL05760 antikoerper, CC1G_06292 antikoerper, PAS_chr3_0761 antikoerper, CGB_A5470W antikoerper, CGB_D1240C antikoerper, crata antikoerper
    Hintergrund
    Carnitine acetyltransferase (CRAT) is a key enzyme in the metabolic pathway in mitochondria, peroxisomes and endoplasmic reticulum. CRAT catalyzes the reversible transfer of acyl groups from an acyl-CoA thioester to carnitine and regulates the ratio of acylCoA/CoA in the subcellular compartments. Different subcellular localizations of the CRAT mRNAs are thought to result from alternative splicing of the CRAT geneuggested by the divergent sequences in the 5' region of peroxisomal and mitochondrial CRAT cDNAs and the location of an intron where the sequences diverge.
    Molekulargewicht
    51 kDa (MW of target protein)
    Pathways
    Monocarboxylic Acid Catabolic Process
Sie sind hier:
Kundenservice